The stock of Covalon Technologies Ltd (CVE:COV) is a huge mover today! About 7,530 shares traded hands. Covalon Technologies Ltd (CVE:COV) has risen 6.00% since August 14, 2016 and is uptrending. It has underperformed by 10.49% the S&P500.
The move comes after 7 months positive chart setup for the $31.41M company. It was reported on Sep, 13 by Barchart.com. We have $5.02 PT which if reached, will make CVE:COV worth $37.38M more.
Covalon Technologies Ltd. is a researcher, developer, maker and marketer of medical products intended for wound care, infection management and surgical procedures. The company has a market cap of $31.41 million. The Company’s wound care dressing products include ColActive Plus, ColActive Transfer, CovaWound Silicone, CovaWound Silicone Sacrum, CovaWound Foam, CovaWound Alginate, CovaWound Super Absorbent and CovaWound Hydrocolloid. It currently has negative earnings. The Company’s surgical and peri-operative products include SurgiClear, MediClear Post-Op Absorb and MediClear Scar.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.